• Our Company
    • Our Mission & Commitment
    • Key Facts
    • Leadership
    • Governance
    • History
    • Compliance & Ethics
    • Diversity & Inclusion
    • Our Websites
    • Achievements
    • Business Information
  • R&D
    • R&D Strategy
    • In the Pipeline
    • Investigational Compound News
    • Disease Areas of Focus
    • Our R&D
    • Our Science
    • R&D Highlights
    • Major R&D Facilities
    • Clinical Trials
  • Products
    • Patient Assistance Programs
    • Prescribing Information
    • R&D
    • Clinical Trials
    • Counterfeit Drugs
    • Product Information Inquiries
  • News
    • Press Releases
    • Publications
    • Media Library
    • Key Facts
    • Leadership
    • Financial Reporting
    • Features
    • Achievements
    • Media Contacts
    • Subscribe to e-mail alerts
  • Investors
    • Key Facts
    • Stock Information
    • SEC Filings
    • Financial Reporting
    • Events & Presentations
    • Shareholder Services
    • Investor Contacts
  • Partnering
    • Why Partner With Us?
    • Areas of Interest
    • Our Process
    • Our Partners
    • Partnering News
    • Partnering Contact
  • Responsibility
    • Bristol-Myers Squibb Foundation
    • Sustainability
    • Patient Assistance Programs
    • Building Our Communities
    • Grants & Giving
    • Position on Key Issues
    • Clinical Trials
    • Combating Counterfeit Drugs
    • Achievements
  • Careers
    • Job Opportunities
    • Our Culture
    • Diversity & Inclusion
    • Developing Our People
    • University Recruitment
    • Achievements
    • Benefits
    • Manage My Profile
    • Apply Now
Go Search

SITE INDEX|CONTACT US|TERMS|PRIVACY
July 2010
Statement on BMS
HIV/AIDS Access Programs
for Least Developed Countries

Statement on HIV/AIDS
Medicine Access in the U.S.

Statement on
VIDEX® (didanosine) Supply

July 12, 2010
COUMADIN® (warfarin sodium)
1 mg Blister Packs
Recall Information
Health Care Professionals Access medical information and resources
Clinical Trials Clinical trials sponsored by Bristol-Myers Squibb
Bristol-Myers Squibb clinical trials for cancer
Need Help Paying for Your Bristol-Myers Squibb Medicines? Learn about our assistance programs.
Our Environmental
Stewardship


 
Supporting Innovations in Mental Health
Bristol-Myers Squibb Foundation: Supporting Innovations in Mental HealthProject seeks to lower recidivism in people with serious mental illness.

 
LATEST NEWS
July 22, 2010Bristol-Myers Squibb National Survey Finds a Disparity Between Health Care Providers and HIV Positive Patients Perspectives on the Emotional Barriers to Seeking HIV Care and TreatmentJuly 22, 2010Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS GrowthJuly 13, 2010Bristol-Myers Squibb to Announce Results for Second Quarter 2010 on July 22July 9, 2010SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
 

News RSSGet RSS News Alerts
BMS TwitterFollow us on twitter.com/bmsnews
 
 
 

© 2010 Bristol-Myers Squibb
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.